Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression - Wikidata - awgldk - TriplyDB

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression

http://www.wikidata.org/entity/Q28282754

about

Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment Metabolomics in rheumatic diseases: desperately seeking biomarkers Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy.A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2 A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling Choline metabolism in malignant transformation.Characterization of human bladder cell membrane during cancer transformation.Choline kinase inhibition in rheumatoid arthritis.Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition.PET Tracers for Clinical Imaging of Breast Cancer.Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.Characterization of choline kinase in human endothelial cells.A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.MR evaluation of response to targeted treatment in cancer cells.Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics.The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.

P2860

Q24317541-C8B3FE2B-F5E3-4D15-AB52-18FCC704E84A Q26765005-9BB9964A-FA83-46BB-92BD-55AAD9E1B4B2 Q28074613-2B8CFF4C-77C9-47A2-BBE0-207801ED97F1 Q28550472-D54F104C-D5F4-473D-9A53-0F90052E3AD5 Q28550634-488C69AB-9AF7-45C2-A70F-231B781DD926 Q30424954-7D12DC85-AB5D-4A97-A778-43B914942BA8 Q33631482-19526D57-692F-4EF0-9FAA-A1EB07B40359 Q33660965-9BB5C0AA-E9BA-469B-A94B-D69836196F95 Q33699139-1330215C-34F8-4B7B-86BD-9E8B97C7F89B Q33714951-61E02855-F6B1-4B12-A751-B2177391217E Q33828887-60CE20B6-5989-4A17-B284-B47A72ABFD99 Q34012467-DA59E3F2-322B-494B-B762-16AF2A6079A0 Q34020037-99BEE75B-47F1-43EE-BC63-833CEF6F6A6E Q34140986-E6E10D9D-195F-41D5-B160-3896AE325F7F Q34447257-2FF0CE9F-D658-4704-99CA-E6AB991667D8 Q34788629-F585F413-759A-4080-AD2D-39E71565707A Q34989144-0FFE072A-BCC1-4C36-8D8F-8D5DFCB1A96C Q35106366-032D8F6E-C0A2-4728-9C51-9674A66D317B Q35112040-BF9754E2-D7E9-4DB6-AEDF-09D328C321FD Q35236992-00FD358A-1FEE-4556-BF45-461B3801B855 Q35243831-A5BA75D1-F5B9-4F16-82A6-9E4C57CAC931 Q35374872-0F3DD600-7E88-4D07-BFC3-AE0E9F89C8A5 Q35602890-CDB70A3E-A262-4859-B1C0-A37C5A85A374 Q35987985-22349054-294D-47E4-A6BD-2066AC43D3B1 Q36009615-108A7C4A-019F-47EC-8179-9B1551BB3195 Q36221080-B90AD081-F83E-42DB-ABAA-D0749CE4F47A Q36630017-32E25032-D03C-4C44-8D25-794FEE019664 Q36748138-190C8A69-CFEC-40AE-83BB-0AD1A4A7AEDA Q36903072-48CBF327-C50C-432B-8BAF-F38E547A52A0 Q36910668-3D924798-A6C4-4865-A694-BE66CCCA9390 Q37165855-3F0CD45D-6CE2-4B2B-8ED2-A79A76E19E19 Q37239363-C03BD565-612C-46EB-A24D-D27061CDFEF8 Q37349124-928FCA2B-4887-4D8D-A443-D63C2CDB98EF Q37392918-F24AF412-DDF4-4E56-A75C-A839FDF16CCE Q37576912-73243018-EAB5-4BBF-A053-7F1004C778FB Q37638188-1EDB2CF4-9223-44FE-B054-99446EECD423 Q37687048-139AAB9E-76C9-40C2-A410-E54579B9950C Q37851076-2E57E0B0-C94E-4799-A230-C5E21C6E48E3 Q37921956-792FE20A-7404-46A6-A38E-4301F0151FCF Q38076754-52EFA1E7-DC21-44E9-9D2D-B6F74551F06F

P2860

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression

http://www.wikidata.org/entity/Q28282754

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Choline kinase activation is a ...... s and breast tumor progression

@ast

Choline kinase activation is a ...... s and breast tumor progression

@en

Choline kinase activation is a ...... s and breast tumor progression

@nl

type

label

Choline kinase activation is a ...... s and breast tumor progression

@ast

Choline kinase activation is a ...... s and breast tumor progression

@en

Choline kinase activation is a ...... s and breast tumor progression

@nl

prefLabel

Choline kinase activation is a ...... s and breast tumor progression

@ast

Choline kinase activation is a ...... s and breast tumor progression

@en

Choline kinase activation is a ...... s and breast tumor progression

@nl

P1433

Q28282754-DD3AAB41-C481-46BE-911E-FFFB52BEDD90

P1476

Q28282754-CF6E07A1-81BC-4F5E-A85E-F4A96A11274F

P2093

Q28282754-1979526E-8F7A-42CF-9F73-A87B4524231B

Q28282754-33BD446A-C87D-4F58-A476-7BFCAB1D8D99

Q28282754-3472D22A-08D3-4CD0-8E8C-ECC23760D1D2

Q28282754-4A3A80B2-7E3F-4506-97D4-ADFA6593643C

Q28282754-777B2C24-ED0B-4307-BF39-118550EA6CA9

Q28282754-A7032072-6B72-4028-84FB-3829810567EC

Q28282754-C37BFE88-5F62-4EB8-8F58-0C1C2642041E

P304

Q28282754-DFCD5AF9-7489-45BB-ADEF-C68ED4A5D035

P31

Q28282754-62E4A532-A163-4BA8-A126-FA03FCE11BFE

P3181

Q28282754-43D77391-E1E8-4E53-8765-0C388D774549

P356

Q28282754-B7CA0609-724F-4E80-B13A-FFC73B6A0A54

P407

Q28282754-E25808C4-534C-4902-B8B5-C061672C87E2

P433

Q28282754-6180A4C1-031C-46A0-A5CA-BDF94D57E85B

P478

Q28282754-E8748F03-DAFF-4B52-8F99-DB1128BB5B3B

P577

Q28282754-BC6851AD-A859-4C3B-B7C2-3C6BF97A12B9

P5875

Q28282754-DD8A78DE-6877-483E-81BA-80BED92ABA22

P698

Q28282754-A7FE0BEC-CD06-4BD0-93A3-4846A6989F68

P3181

P356

0008-5472.CAN-04-0489

P1433

Cancer Research

P1476

Choline kinase activation is a ...... s and breast tumor progression

@en

P2093

Agustín Rodríguez-González

http://www.w3.org/2001/XMLSchema#string

Ana Ramírez de Molina

http://www.w3.org/2001/XMLSchema#string

David Olmeda

http://www.w3.org/2001/XMLSchema#string

Diego Megías

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Lacal

http://www.w3.org/2001/XMLSchema#string

Mónica Báñez-Coronel

http://www.w3.org/2001/XMLSchema#string

Ruth Gutiérrez

http://www.w3.org/2001/XMLSchema#string

P304

6732-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1836740

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-04-0489

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8339487

http://www.w3.org/2001/XMLSchema#string

P698

15374991

http://www.w3.org/2001/XMLSchema#string